FDA Rejects MDMA-AT for PTSD, but Lykos Vows to Push on

Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and layoffs of 75% of company staff.
Medscape Medical News

source https://www.medscape.com/viewarticle/fda-rejects-mdma-ptsd-lykos-others-vow-push-2024a1000fvl?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost